Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

Next week is seeing many companies report their Q2 earnings performance - do you have a watch-list prepared? If you’re interested in the biotech industry, you may find this list very interesting.

We screened next week’s reporting companies from the biotech industry for those that have seen a bullish change in sentiment, indicated by a significant decrease in the put/call ratio over the last ten days.

Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for the top six stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 (NYSEARCA:SPY) index over the last month.

(Click chart for more detail)

Do you think these companies will surprise us? Use this list as a starting-off point for your own analysis.

List sorted by decrease in put/call ratio.

1. Exact Sciences Corporation (NASDAQ:EXAS): Biotechnology Industry. Market cap of $452.75M. Company to release earnings on 08/02. Put/call ratio has decreased 48.31% (from 0.89 to 0.46). The stock is a short squeeze candidate, with a short float at 13.02% (equivalent to 11.07 days of average volume). The stock has gained 120.61% over the last year.

2. Sequenom Inc. (NASDAQ:SQNM): Biotechnology Industry. Market cap of $726.11M. Company to release earnings on 08/04. Put/call ratio has decreased 39.13% (from 0.23 to 0.14). The stock is a short squeeze candidate, with a short float at 20.73% (equivalent to 9.89 days of average volume). The stock has gained 26.16% over the last year.

3. Medicis Pharmaceutical Corp. (MRX): Biotechnology Industry. Market cap of $2.32B. Company to release earnings on 08/02. Put/call ratio has decreased 35.59% (from 0.59 to 0.38). The stock has gained 45.11% over the last year.

4. Exelixis, Inc. (NASDAQ:EXEL): Biotechnology Industry. Market cap of $1.01B. Company to release earnings on 08/04. Put/call ratio has decreased 28.21% (from 0.78 to 0.56). The stock is a short squeeze candidate, with a short float at 10.09% (equivalent to 8.41 days of average volume). It's been a rough couple of days for the stock, losing 10.65% over the last week.

5. Acorda Therapeutics, Inc. (NASDAQ:ACOR): Biotechnology Industry. Market cap of $1.13B. Company to release earnings on 08/01. Put/call ratio has decreased 26.92% (from 0.78 to 0.57). The stock is a short squeeze candidate, with a short float at 12.66% (equivalent to 6.46 days of average volume). The stock has performed poorly over the last month, losing 12.59%.

6. Immunogen Inc. (NASDAQ:IMGN): Biotechnology Industry. Market cap of $950.08M. Company to release earnings on 08/04. Put/call ratio has decreased 26.09% (from 0.46 to 0.34). The stock is a short squeeze candidate, with a short float at 9.5% (equivalent to 9.17 days of average volume). It's been a rough couple of days for the stock, losing 8.09% over the last week. The stock has had a good month, gaining 20.1%.

7. Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR): Biotechnology Industry. Market cap of $511.24M. Company to release earnings on 08/03. Put/call ratio has decreased 23.08% (from 0.26 to 0.20). The stock is a short squeeze candidate, with a short float at 12.02% (equivalent to 6.49 days of average volume). The stock has gained 14.18% over the last year.

8. Dendreon Corp. (NASDAQ:DNDN): Biotechnology Industry. Market cap of $5.56B. Company to release earnings on 08/03. Put/call ratio has decreased 17.31% (from 0.52 to 0.43). The stock is a short squeeze candidate, with a short float at 10.97% (equivalent to 5.91 days of average volume). The stock has gained 9.35% over the last year.

9. Emergent BioSolutions, Inc. (NYSE:EBS): Biotechnology Industry. Market cap of $754.23M. Company to release earnings on 08/04. Put/call ratio has decreased 16.67% (from 0.24 to 0.20). The stock is a short squeeze candidate, with a short float at 5.19% (equivalent to 5.03 days of average volume). The stock has gained 11.79% over the last year.

10. MannKind Corp. (NASDAQ:MNKD): Biotechnology Industry. Market cap of $449.57M. Company to release earnings on 08/03. Put/call ratio has decreased 12.50% (from 0.32 to 0.28). The stock is a short squeeze candidate, with a short float at 26.43% (equivalent to 19.94 days of average volume). It's been a rough couple of days for the stock, losing 6.27% over the last week.

*Options data sourced from Schaeffer’s, all other data sourced from Finviz.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Source: 10 Biotech Companies With Bullish Options Sentiment Reporting Earnings Next Week